What question did this study set out to answer?

To identify malignant T-cell states and immune circuits in Sézary syndrome through single-cell analysis.

March 5, 2026

Mapping malignant T-cell states and immune circuits in Sézary syndrome by single-cell analysis.

BCBeth ChildsThe University of Texas Southwestern Medical Center EEEslam A. Elghonaimy PGPraveen Ramakrishnan Geethakumari

Key Points

To identify malignant T-cell states and immune circuits in Sézary syndrome through single-cell analysis.
Conducted a single-cell analysis of leukaemic CTCL samples.
Characterized T-cell states and KIR expression patterns.
Proposed mechanisms of immune evasion related to treatment resistance.
Identified new malignant T-cell states in Sézary syndrome.
Expounded upon the repertoire of KIR (Killer Cell Immunoglobulin-like Receptor) expression.
Suggested immune evasion mechanisms contributing to treatment resistance.

Abstract

This is one of the most comprehensive single-cell studies of leukaemic CTCL to date. We uncover new malignant T-cell states, broaden the known repertoire of KIR expression, and propose mechanisms of immune evasion that may contribute to treatment resistance. These findings lay the groundwork for subtype-specific and microenvironment-informed therapeutic strategies in Sézary syndrome, with potential implications for guiding targeted therapy selection but require validation in larger, independent cohorts.

Perguntar à IA

Bookmark

View Full Paper